Test ID: FSMS
Smith-Magenis/Potocki-Lupski Syndromes, 17p11.2 Deletion/Duplication, FISH
Method Description
Describes how the test is performed and provides a method-specific reference
Identification of deletions or duplications of 17p11.2 associated with Smith-Magenis/Potocki-Lupski syndromes is based on FISH analysis of the critical RAI1 region (RAI1)on the short arm of chromosome 17 (17p11.2). Metaphase cells are examined for the presence of 2 critical region loci at 17p11.2 (orange signal) and the control probe (47G8) at 17q21.1 (green signal). In metaphase cells with a deletion, the abnormal (deleted) chromosome 17 will exhibit only a control probe signal, while signals for both the critical region and control probes will be present on the normal chromosome 17 homolog. If metaphase analysis is normal, 200 interphase nuclei are scored for the presence of 3 orange signals, which is consistent with duplication (RP11-1149K20).(Crifasi PA, Michels VV, Driscoll DJ, et al: DNA fluorescent probes for diagnosis of velocardiofacial and related syndromes. Mayo Clin Proc 1995;70[12]:1148-1153)
Day(s) and Time(s) Test Performed
Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Samples processed Monday through Sunday. Results reported Monday through Friday, 8 a.m.-5 p.m. CST.


